Durham, North Carolina (December 5, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the recent appointment of Maggie Chen, Senior Vice President and Site Head of the Patriot Park mammalian cGMP manufacturing facility...
Read More
Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes. Durham, North Carolina (September 12,...
Durham, North Carolina (August 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced four recent executive appointments...
KBI's PUREplatform™ is a game-changing microbial expression offering that redefines biopharmaceutical manufacturing. The platform leverages the...
The recent operational consolidation of KBI Biopharma, Inc. and Selexis SA brings a streamlined approach to support customers in rapidly accelerating...
Platform leverages proprietary PUREcoli™ strain and cutting-edge screening packages for unmatched efficiencies and optimized production processes ...
KBI’s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers Sunnyvale,...
Durham, North Carolina (May 10, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the appointment of Marykay...
Durham, North Carolina (April 17, 2023) – KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment...
Milestone affirms KBI and Selexis SA’s Geneva cGMP site is operational and running successfully. GENEVA, March 21, 2023 – KBI Biopharma, Inc....
